The landscape of targeted cancer therapy is undergoing a significant paradigm shift following recent clinical disclosures at the European Society…
Read More
Gilead Sciences and Vir Biotechnology Expand Strategic Oncology Partnership in Multi-Billion-Dollar T-Cell Engager Deal for Solid Tumors
Gilead Sciences and Vir Biotechnology have significantly expanded their strategic research and development alliance through a newly finalized licensing agreement…
Read More
Navigating the Frontiers of Oncology: Insights, Challenges, and Inspiration from the American Association for Cancer Research Annual Meeting
The American Association for Cancer Research Annual Meeting stands as one of the premier global gatherings for oncology professionals, bringing…
Read More
AI-Driven Oncology Pioneer Iambic Therapeutics Targets $135m Nasdaq IPO in Banner Year for Biotech Listings
Iambic Therapeutics, an oncology-focused biotechnology company recognized for its pioneering intersection of artificial intelligence and drug discovery, has officially set…
Read More
AstraZeneca and Daiichi Sankyo Join Forces with Summit Therapeutics in Strategic Clinical Partnership to Evaluate Novel Oncology Combinations
The oncology landscape is undergoing a significant strategic consolidation as major pharmaceutical players align their pipelines to maximize the therapeutic…
Read More
MSD Strengthens Oncology Pipeline with Multi-Billion-Dollar Licensing Deal for Shanghai-Based SciBrunch Therapeutics KRAS Inhibitor SPR2015
In a strategic move to fortify its oncology portfolio against looming patent expirations, MSD—known as Merck & Co. in the…
Read More
AstraZeneca Deepens Oncology Footprint with $2bn Equity Investment in Summit Therapeutics to Advance Next-Generation Cancer Combinations
AstraZeneca has announced a landmark $2bn equity investment in Summit Therapeutics, marking a major strategic alignment between the pharmaceutical giants…
Read More
Unlocking the Genetic Black Box: Large-Scale Study Reveals New Insights Into Feline Cancer and Human Oncology
For decades, the genetic landscape of feline cancer has remained a proverbial black box, leaving veterinarians and researchers to treat…
Read More
Eli Lilly and InnoCare Pharma Forge $3.35bn R&D Partnership to Tackle Oncology and Autoimmune Diseases
Eli Lilly and Company has entered into a sweeping, five-drug research and licensing agreement with China-based biopharmaceutical firm InnoCare Pharma,…
Read More
Roche Deepens AI and Small Molecule Strategy with Multi-Billion-Dollar Partnerships in Oncology and CVRM
Swiss pharmaceutical giant Roche, acting through its subsidiary Genentech, has entered a blockbuster agreement with Earendil Labs, committing up to…
Read More
